About 41,840 results

ALLMedicine™ Cirrhosis Center

Research & Reviews  14,146 results

Health-Related Quality of Life and Its Influencing Factors in Patients with Hepatitis B...
Canadian Journal of Gastroenterology & Hepatology; Chen P, Zhang F et. al.

Jul 26th, 2021 - Health-related quality of life (HRQoL) is an important aspect in the management of patients with hepatitis B (HB), which remains a serious health problem in China. There have been relatively few HRQoL studies involving Chinese patients with HB. Th...

Cirrhosis in a 42 Year Old With a History of Attempted Atrial Septal Defect Closure in ...
Circulation. Cardiovascular Imaging; Stockdale G, Breinholt JP et. al.

Jul 26th, 2021 - Cirrhosis in a 42 Year Old With a History of Attempted Atrial Septal Defect Closure in Childhood.|2021|Stockdale G,Breinholt JP,Ellsworth E,Bhatia N,Franklin WJ,|

Liver-resident bystander CD8+ T cells contribute to liver disease pathogenesis in chron...
Gastroenterology Kefalakes H, Horgan XJ et. al.

Jul 24th, 2021 - The hepatitis D virus (HDV) causes the most severe form of chronic hepatitis, often progressing to cirrhosis within 5-10 years. There is no curative treatment and the mechanisms underlying the accelerated liver disease progression are unknown. Inn...

Treatment and outcomes of hepatocellular carcinoma in patients with Sickle cell disease...
HPB : the Official Journal of the International Hepato Pa... Barbetta A, Goldbeck C et. al.

Jul 23rd, 2021 - Sickle cell disease (SCD) is a rare hemoglobinopathy which can result in chronic liver disease and cirrhosis. Patients with SCD have an increased risk of hematologic malignancy, but the prevalence of hepatocellular carcinoma (HCC) in this populati...

Long working hours are associated with a higher risk of non-alcoholic fatty liver disea...
PloS One; Lee Y, Mun E et. al.

Jul 23rd, 2021 - Non-alcoholic fatty liver disease (NAFLD), a common chronic liver disease, may progress to fibrosis, cirrhosis, hepatocellular carcinoma, and liver failure. But only a few cross-sectional studies have reported an association of NAFLD with working ...

see more →

Guidelines  27 results

ACR Appropriateness Criteria® Radiologic Management of Portal Hypertension.
Journal of the American College of Radiology : JACR; , Pinchot JW et. al.

May 7th, 2021 - Cirrhosis is a heterogeneous disease that cannot be studied as a single entity and is classified in two main prognostic stages: compensated and decompensated cirrhosis. Portal hypertension, characterized by a pathological increase of the portal pr...

AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.
Clinical Gastroenterology and Hepatology : the Official C... Patton H, Heimbach J et. al.

Jan 4th, 2021 - AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.|2021|Patton H,Heimbach J,McCullough A,|

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achie...
Gastroenterology Younossi ZM, Corey KE et. al.

Dec 11th, 2020 - Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with global public health impact affecting more than 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, h...

AGA Clinical Practice Update on Palliative Care Management in Cirrhosis: Expert Review.
Clinical Gastroenterology and Hepatology : the Official C... Tandon P, Walling A et. al.

Nov 22nd, 2020 - Care with palliative care principles (aka Palliative Care, PC) is an approach to care that focuses on improving the quality of life of patients and their caregivers who are facing life-limiting illness. It encompasses the assessment and management...

ACR Appropriateness Criteria® Radiologic Management of Gastric Varices.
Journal of the American College of Radiology : JACR; , Kim CY et. al.

May 6th, 2020 - Hemorrhage, resulting from gastric varies, can be challenging to treat, given the various precipitating etiologies. A wide variety of treatment options exist for managing the diverse range of the underlying disease processes. While cirrhosis is th...

see more →

Drugs  604 results see all →

Clinicaltrials.gov  738 results

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

May 6th, 2020 - The main reason for this study is to see how the study drug interacts with the body. It will compare different doses of the study drug with a drug already in use. Participants will be adults with liver disease that has affected the brain in the past.

Oral Microbiome of Patients With Hepatitis C Virus Infection

Apr 23rd, 2020 - Human oral cavity is a great habitat for more than 600 species of bacteria, known as oral microbiota, living in equilibrium. Oral microbiota plays an important role in maintaining oral health; however when the balance in oral bacterial population ...

Low-Dose Danazol for the Treatment of Telomere Related Diseases

Apr 20th, 2020 - Telomere disease is caused by accelerated telomere attrition and results in multi-organ dysfunction. Telomeres are nucleotide repeats of non-coding DNA at the end of the chromosomes which function as protective caps to prevent erosion of genomic D...

Treatment of Hemochromatosis

Apr 19th, 2020 - Hereditary hemochromatosis (HH) occurs in 1 in every 200-250 individuals of northern European descent, and is the most common inherited disease in this population. Although the molecular pathophysiology remains incompletely understood, a homozygou...

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

Apr 19th, 2020 - Chronic viral hepatitis is a major health problem affecting millions globally. The immunosuppressed population, especially those with HIV infection, remains at particular risk and the incidence of hepatocellular carcinoma (HCC) is increasing in th...

see more →

News  1,175 results

Study Supports Chemopreventive Effect of Statins on Liver Cancer in NASH Cirrhosis

Jul 19th, 2021 - NEW YORK (Reuters Health) - New research provides supporting evidence for chemopreventive effects of statins on hepatocellular carcinoma (HCC) in patients with nonalcoholic steatohepatitis (NASH) cirrhosis. In the American Journal of Gastroenterol...

Novel Liver Dialysis Device May Safely Curb Acute-on-Chronic Liver Failure

Jun 30th, 2021 - An investigational liver dialysis device (DIALIVE) was associated with significantly greater survival of patients with acute-on-chronic liver failure (ACLF), compared with the standard of care in a multicenter randomized study. Among 30 evaluable ...

The Sick-Quitter Effect: How Alcohol Can Seem Cardioprotective When It Isn't

Jun 28th, 2021 - People ask me if they should drink more red wine. They ask me this repeatedly. Ever since 60 Minutes ran their story on the French Paradox, people are fixated on the idea that red wine can lower your risk of having a heart attack even if everythin...

Patients With Advanced Liver Cancer Prefer Atezolizumab Combo

Jun 15th, 2021 - NEW YORK (Reuters Health) - Patients with unresectable hepatocellular carcinoma report that quality of life, functioning and disease symptoms are improved with atezolizumab plus bevacizumab compared with sorafenib, according to prespecified analys...

On the Waterfront

Jun 8th, 2021 - Getting old? Stinks. On ice. Last week I had night call and then on-call this weekend. And I am pooped. I have nowhere near the stamina I did even last year. And time off does not energize me for work; it only makes me want more time off. My big m...

see more →

Patient Education  46 results see all →